Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Genmab A/S: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

19 Apr 2014 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Genmab A/S

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

19 Apr 2014 Wright Reports 42 $75.00

Genmab A/S (GEN) - Financial and Strategic SWOT Analysis Review

Genmab A/S (GEN) - Financial and Strategic SWOT Analysis Review Summary Genmab A/S (Genmab) is a biotechnology company. It de...

10 Apr 2014 GlobalData 40 $125.00

Genmab A/S

Genmab A/S - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the comp...

08 Apr 2014 MarketLine (a Datamonitor Company) 43 $175.00

Genmab A/S (GEN) - Financial and Strategic SWOT Analysis Review

Genmab A/S (GEN) - Financial and Strategic SWOT Analysis Review Summary Genmab A/S (Genmab) is a biotechnology company. It de...

27 Mar 2014 GlobalData 40 $125.00

Genmab A/S (GEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genmab A/S (GEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Genmab A/S (Genmab) is a biotechnology ...

17 Feb 2014 GlobalData 39 $250.00

Genmab A/S (GEN) - Financial and Strategic SWOT Analysis Review

Genmab A/S (GEN) - Financial and Strategic SWOT Analysis Review Summary Genmab A/S (Genmab) is a biotechnology company. It de...

10 Jan 2014 GlobalData 41 $125.00

Genmab A/S (GEN) - Financial and Strategic SWOT Analysis Review

Genmab A/S (GEN) - Financial and Strategic SWOT Analysis Review Summary Genmab A/S (Genmab) is a biotechnology company. It de...

20 Dec 2013 GlobalData 41 $125.00

GENMAB - CUTTING A DASH AT ASH

Expanding Arzerra’s label should help drive uptake of Genmab/GSK’s approved antibody. Detailed data from the positive front-l...

15 Nov 2013 Edison Investment Research 2 $10.00

Genmab A/S (GEN) - Financial and Strategic SWOT Analysis Review

Genmab A/S (GEN) - Financial and Strategic SWOT Analysis Review Summary Genmab A/S (Genmab) is a biotechnology company. It de...

07 Oct 2013 GlobalData 41 $125.00